Cassia-17b is an advanced phytotherapeutic formulation developed from rare wild plants of the Arabian desert. This formula is rich in bioactive secondary metabolites, which exhibit a broad spectrum of biological activities with strong therapeutic potential for supporting patients with severe malignant brain conditions and associated neurological disorders.
Cassia-17b is enriched with bioactive secondary metabolites including flavonoids, phenols, tannins, saponins, triterpenoids, alkaloids, and other phytochemicals with synergistic effects.